image
image
user-login
arrow
Novo Nexus Pharmaceuticals SATISH KHACHNE.
Novo Nexus Pharmaceuticals

Novo Nexus Pharmaceuticals
SATISH KHACHNE.

Novo Nexus Pharmaceuticals is a Trademark filed on Jan 13, 2016 in through IP Office.The Trademark is registered to SATISH KHACHNE. and was filed by attorney.

Novo Nexus Pharmaceuticals

Novo Nexus Pharmaceuticals SATISH KHACHNE. Trademark Information

Application ID

3158322

Status

Registered

Date of Application

Jan 13, 2016

Classes

5

Proprietor(s)

SATISH KHACHNE.

Published

Sept 05, 2016

Valid/Upto

13/01/2026

FAQs

The application for Novo Nexus Pharmaceuticals was made on Jan 13, 2016
The trademark applicant for Novo Nexus Pharmaceuticals is SATISH KHACHNE..
Trademark application has been filed under the class(es) 5.
As per IP India, trademark application is on the following stage: Registered.
Listed application Id of Novo Nexus Pharmaceuticals is 3158322.
Novo Nexus Pharmaceuticals Trademark is a undefined mark.
Disclaimer: Vakilsearch assumes no responsibility or liability for any errors or omissions in the content of this page. The data is derived from mca.gov.in and ipindia.gov.in
bulb
Don’t lose your brand like ”
Our experts are here to assist you in finding a similar trademark.
  • No results found
1 Lakh+
TM Registered since 2011
trademark
star
4.5/5
(19k+ reviews)
google

footer-service

By continuing past this page, you agree to our Terms of Service Cookie Policy Privacy Policy  and  Refund Policy  © - Uber9 Business Process Services Private Limited. All rights reserved.

Uber9 Business Process Services Private Limited, CIN - U74900TN2014PTC098414, GSTIN - 33AABCU7650C1ZM, Registered Office Address - F-97, Newry Shreya Apartments Anna Nagar East, Chennai, Tamil Nadu 600102, India.

Please note that we are a facilitating platform enabling access to reliable professionals. We are not a law firm and do not provide legal services ourselves. The information on this website is for the purpose of knowledge only and should not be relied upon as legal advice or opinion.